Summary
According to APO Research, The global Medical Radioisotopes market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Medical Radioisotopes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Medical Radioisotopes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Medical Radioisotopes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Medical Radioisotopes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Medical Radioisotopes, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Medical Radioisotopes, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Radioisotopes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Radioisotopes revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Medical Radioisotopes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Medical Radioisotopes revenue, projected growth trends, production technology, application and end-user industry.
Medical Radioisotopes segment by Company
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
Medical Radioisotopes segment by Type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Medical Radioisotopes segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
Medical Radioisotopes segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioisotopes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Medical Radioisotopes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Medical Radioisotopes company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Radioisotopes revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Medical Radioisotopes Market by Type
1.2.1 Global Medical Radioisotopes Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Tc-99m
1.2.3 Cobalt-60
1.2.4 Iodine Radioisotopes
1.3 Medical Radioisotopes Market by Application
1.3.1 Global Medical Radioisotopes Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Medical Radioisotopes Market Dynamics
2.1 Medical Radioisotopes Industry Trends
2.2 Medical Radioisotopes Industry Drivers
2.3 Medical Radioisotopes Industry Opportunities and Challenges
2.4 Medical Radioisotopes Industry Restraints
3 Global Growth Perspective
3.1 Global Medical Radioisotopes Market Perspective (2019-2030)
3.2 Global Medical Radioisotopes Growth Trends by Region
3.2.1 Global Medical Radioisotopes Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Medical Radioisotopes Market Size by Region (2019-2024)
3.2.3 Global Medical Radioisotopes Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Medical Radioisotopes Revenue by Players
4.1.1 Global Medical Radioisotopes Revenue by Players (2019-2024)
4.1.2 Global Medical Radioisotopes Revenue Market Share by Players (2019-2024)
4.1.3 Global Medical Radioisotopes Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Medical Radioisotopes Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Medical Radioisotopes Key Players Headquarters & Area Served
4.4 Global Medical Radioisotopes Players, Product Type & Application
4.5 Global Medical Radioisotopes Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Medical Radioisotopes Market CR5 and HHI
4.6.2 Global Top 5 and 10 Medical Radioisotopes Players Market Share by Revenue in 2023
4.6.3 2023 Medical Radioisotopes Tier 1, Tier 2, and Tier 3
5 Medical Radioisotopes Market Size by Type
5.1 Global Medical Radioisotopes Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Medical Radioisotopes Revenue by Type (2019-2030)
5.3 Global Medical Radioisotopes Revenue Market Share by Type (2019-2030)
6 Medical Radioisotopes Market Size by Application
6.1 Global Medical Radioisotopes Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Medical Radioisotopes Revenue by Application (2019-2030)
6.3 Global Medical Radioisotopes Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 NRG
7.1.1 NRG Comapny Information
7.1.2 NRG Business Overview
7.1.3 NRG Medical Radioisotopes Revenue and Gross Margin (2019-2024)
7.1.4 NRG Medical Radioisotopes Product Portfolio
7.1.5 NRG Recent Developments
7.2 IRE
7.2.1 IRE Comapny Information
7.2.2 IRE Business Overview
7.2.3 IRE Medical Radioisotopes Revenue and Gross Margin (2019-2024)
7.2.4 IRE Medical Radioisotopes Product Portfolio
7.2.5 IRE Recent Developments
7.3 ANSTO
7.3.1 ANSTO Comapny Information
7.3.2 ANSTO Business Overview
7.3.3 ANSTO Medical Radioisotopes Revenue and Gross Margin (2019-2024)
7.3.4 ANSTO Medical Radioisotopes Product Portfolio
7.3.5 ANSTO Recent Developments
7.4 NTP Radioisotopes
7.4.1 NTP Radioisotopes Comapny Information
7.4.2 NTP Radioisotopes Business Overview
7.4.3 NTP Radioisotopes Medical Radioisotopes Revenue and Gross Margin (2019-2024)
7.4.4 NTP Radioisotopes Medical Radioisotopes Product Portfolio
7.4.5 NTP Radioisotopes Recent Developments
7.5 China National Nuclear Corporation
7.5.1 China National Nuclear Corporation Comapny Information
7.5.2 China National Nuclear Corporation Business Overview
7.5.3 China National Nuclear Corporation Medical Radioisotopes Revenue and Gross Margin (2019-2024)
7.5.4 China National Nuclear Corporation Medical Radioisotopes Product Portfolio
7.5.5 China National Nuclear Corporation Recent Developments
7.6 Rosatom
7.6.1 Rosatom Comapny Information
7.6.2 Rosatom Business Overview
7.6.3 Rosatom Medical Radioisotopes Revenue and Gross Margin (2019-2024)
7.6.4 Rosatom Medical Radioisotopes Product Portfolio
7.6.5 Rosatom Recent Developments
7.7 Nordion
7.7.1 Nordion Comapny Information
7.7.2 Nordion Business Overview
7.7.3 Nordion Medical Radioisotopes Revenue and Gross Margin (2019-2024)
7.7.4 Nordion Medical Radioisotopes Product Portfolio
7.7.5 Nordion Recent Developments
7.8 Eckert & Ziegler Strahlen
7.8.1 Eckert & Ziegler Strahlen Comapny Information
7.8.2 Eckert & Ziegler Strahlen Business Overview
7.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Revenue and Gross Margin (2019-2024)
7.8.4 Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio
7.8.5 Eckert & Ziegler Strahlen Recent Developments
7.9 Polatom
7.9.1 Polatom Comapny Information
7.9.2 Polatom Business Overview
7.9.3 Polatom Medical Radioisotopes Revenue and Gross Margin (2019-2024)
7.9.4 Polatom Medical Radioisotopes Product Portfolio
7.9.5 Polatom Recent Developments
8 North America
8.1 North America Medical Radioisotopes Revenue (2019-2030)
8.2 North America Medical Radioisotopes Revenue by Type (2019-2030)
8.2.1 North America Medical Radioisotopes Revenue by Type (2019-2024)
8.2.2 North America Medical Radioisotopes Revenue by Type (2025-2030)
8.3 North America Medical Radioisotopes Revenue Share by Type (2019-2030)
8.4 North America Medical Radioisotopes Revenue by Application (2019-2030)
8.4.1 North America Medical Radioisotopes Revenue by Application (2019-2024)
8.4.2 North America Medical Radioisotopes Revenue by Application (2025-2030)
8.5 North America Medical Radioisotopes Revenue Share by Application (2019-2030)
8.6 North America Medical Radioisotopes Revenue by Country
8.6.1 North America Medical Radioisotopes Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Medical Radioisotopes Revenue by Country (2019-2024)
8.6.3 North America Medical Radioisotopes Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Medical Radioisotopes Revenue (2019-2030)
9.2 Europe Medical Radioisotopes Revenue by Type (2019-2030)
9.2.1 Europe Medical Radioisotopes Revenue by Type (2019-2024)
9.2.2 Europe Medical Radioisotopes Revenue by Type (2025-2030)
9.3 Europe Medical Radioisotopes Revenue Share by Type (2019-2030)
9.4 Europe Medical Radioisotopes Revenue by Application (2019-2030)
9.4.1 Europe Medical Radioisotopes Revenue by Application (2019-2024)
9.4.2 Europe Medical Radioisotopes Revenue by Application (2025-2030)
9.5 Europe Medical Radioisotopes Revenue Share by Application (2019-2030)
9.6 Europe Medical Radioisotopes Revenue by Country
9.6.1 Europe Medical Radioisotopes Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Medical Radioisotopes Revenue by Country (2019-2024)
9.6.3 Europe Medical Radioisotopes Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Medical Radioisotopes Revenue (2019-2030)
10.2 China Medical Radioisotopes Revenue by Type (2019-2030)
10.2.1 China Medical Radioisotopes Revenue by Type (2019-2024)
10.2.2 China Medical Radioisotopes Revenue by Type (2025-2030)
10.3 China Medical Radioisotopes Revenue Share by Type (2019-2030)
10.4 China Medical Radioisotopes Revenue by Application (2019-2030)
10.4.1 China Medical Radioisotopes Revenue by Application (2019-2024)
10.4.2 China Medical Radioisotopes Revenue by Application (2025-2030)
10.5 China Medical Radioisotopes Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Medical Radioisotopes Revenue (2019-2030)
11.2 Asia Medical Radioisotopes Revenue by Type (2019-2030)
11.2.1 Asia Medical Radioisotopes Revenue by Type (2019-2024)
11.2.2 Asia Medical Radioisotopes Revenue by Type (2025-2030)
11.3 Asia Medical Radioisotopes Revenue Share by Type (2019-2030)
11.4 Asia Medical Radioisotopes Revenue by Application (2019-2030)
11.4.1 Asia Medical Radioisotopes Revenue by Application (2019-2024)
11.4.2 Asia Medical Radioisotopes Revenue by Application (2025-2030)
11.5 Asia Medical Radioisotopes Revenue Share by Application (2019-2030)
11.6 Asia Medical Radioisotopes Revenue by Country
11.6.1 Asia Medical Radioisotopes Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Medical Radioisotopes Revenue by Country (2019-2024)
11.6.3 Asia Medical Radioisotopes Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Medical Radioisotopes Revenue (2019-2030)
12.2 MEALA Medical Radioisotopes Revenue by Type (2019-2030)
12.2.1 MEALA Medical Radioisotopes Revenue by Type (2019-2024)
12.2.2 MEALA Medical Radioisotopes Revenue by Type (2025-2030)
12.3 MEALA Medical Radioisotopes Revenue Share by Type (2019-2030)
12.4 MEALA Medical Radioisotopes Revenue by Application (2019-2030)
12.4.1 MEALA Medical Radioisotopes Revenue by Application (2019-2024)
12.4.2 MEALA Medical Radioisotopes Revenue by Application (2025-2030)
12.5 MEALA Medical Radioisotopes Revenue Share by Application (2019-2030)
12.6 MEALA Medical Radioisotopes Revenue by Country
12.6.1 MEALA Medical Radioisotopes Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Medical Radioisotopes Revenue by Country (2019-2024)
12.6.3 MEALA Medical Radioisotopes Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Medical Radioisotopes Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Tc-99m Major Manufacturers
Table 2. Cobalt-60 Major Manufacturers
Table 3. Iodine Radioisotopes Major Manufacturers
Table 4. Global Medical Radioisotopes Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Nuclear Therapy Major Manufacturers
Table 6. Equipment Radioactive Source Major Manufacturers
Table 7. Diagnosis Major Manufacturers
Table 8. Others Major Manufacturers
Table 9. Medical Radioisotopes Industry Trends
Table 10. Medical Radioisotopes Industry Drivers
Table 11. Medical Radioisotopes Industry Opportunities and Challenges
Table 12. Medical Radioisotopes Industry Restraints
Table 13. Global Medical Radioisotopes Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Medical Radioisotopes Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Medical Radioisotopes Market Share by Region (2019-2024)
Table 16. Global Medical Radioisotopes Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Medical Radioisotopes Market Share by Region (2025-2030)
Table 18. Global Medical Radioisotopes Revenue by Players (US$ Million) & (2019-2024)
Table 19. Global Medical Radioisotopes Revenue Market Share by Players (2019-2024)
Table 20. Global Medical Radioisotopes Key Players Ranking, 2022 VS 2023 VS 2024
Table 21. Global Medical Radioisotopes Key Players Headquarters & Area Served
Table 22. Global Medical Radioisotopes Players, Product Type & Application
Table 23. Global Medical Radioisotopes Players Commercialization Time
Table 24. Global Players Market Concentration Ratio (CR5 and HHI)
Table 25. Global Medical Radioisotopes by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Medical Radioisotopes Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Medical Radioisotopes Revenue by Type (2019-2024) & (US$ Million)
Table 28. Global Medical Radioisotopes Revenue by Type (2025-2030) & (US$ Million)
Table 29. Global Medical Radioisotopes Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 30. Global Medical Radioisotopes Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 31. Global Medical Radioisotopes Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Medical Radioisotopes Revenue by Application (2019-2024) & (US$ Million)
Table 33. Global Medical Radioisotopes Revenue by Application (2025-2030) & (US$ Million)
Table 34. Global Medical Radioisotopes Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 35. Global Medical Radioisotopes Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 36. NRG Company Information
Table 37. NRG Business Overview
Table 38. NRG Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. NRG Medical Radioisotopes Product Portfolio
Table 40. NRG Recent Development
Table 41. IRE Company Information
Table 42. IRE Business Overview
Table 43. IRE Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. IRE Medical Radioisotopes Product Portfolio
Table 45. IRE Recent Development
Table 46. ANSTO Company Information
Table 47. ANSTO Business Overview
Table 48. ANSTO Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. ANSTO Medical Radioisotopes Product Portfolio
Table 50. ANSTO Recent Development
Table 51. NTP Radioisotopes Company Information
Table 52. NTP Radioisotopes Business Overview
Table 53. NTP Radioisotopes Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. NTP Radioisotopes Medical Radioisotopes Product Portfolio
Table 55. NTP Radioisotopes Recent Development
Table 56. China National Nuclear Corporation Company Information
Table 57. China National Nuclear Corporation Business Overview
Table 58. China National Nuclear Corporation Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. China National Nuclear Corporation Medical Radioisotopes Product Portfolio
Table 60. China National Nuclear Corporation Recent Development
Table 61. Rosatom Company Information
Table 62. Rosatom Business Overview
Table 63. Rosatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. Rosatom Medical Radioisotopes Product Portfolio
Table 65. Rosatom Recent Development
Table 66. Nordion Company Information
Table 67. Nordion Business Overview
Table 68. Nordion Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Nordion Medical Radioisotopes Product Portfolio
Table 70. Nordion Recent Development
Table 71. Eckert & Ziegler Strahlen Company Information
Table 72. Eckert & Ziegler Strahlen Business Overview
Table 73. Eckert & Ziegler Strahlen Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio
Table 75. Eckert & Ziegler Strahlen Recent Development
Table 76. Polatom Company Information
Table 77. Polatom Business Overview
Table 78. Polatom Medical Radioisotopes Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. Polatom Medical Radioisotopes Product Portfolio
Table 80. Polatom Recent Development
Table 81. North America Medical Radioisotopes Revenue by Type (2019-2024) & (US$ Million)
Table 82. North America Medical Radioisotopes Revenue by Application (2019-2024) & (US$ Million)
Table 83. North America Medical Radioisotopes Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 84. North America Medical Radioisotopes Revenue by Country (2019-2024) & (US$ Million)
Table 85. North America Medical Radioisotopes Revenue by Country (2025-2030) & (US$ Million)
Table 86. Europe Medical Radioisotopes Revenue by Type (2019-2024) & (US$ Million)
Table 87. Europe Medical Radioisotopes Revenue by Application (2019-2024) & (US$ Million)
Table 88. Europe Medical Radioisotopes Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 89. Europe Medical Radioisotopes Revenue by Country (2019-2024) & (US$ Million)
Table 90. Europe Medical Radioisotopes Revenue by Country (2025-2030) & (US$ Million)
Table 91. China Medical Radioisotopes Revenue by Type (2019-2024) & (US$ Million)
Table 92. China Medical Radioisotopes Revenue by Application (2019-2024) & (US$ Million)
Table 93. Asia Medical Radioisotopes Revenue by Type (2019-2024) & (US$ Million)
Table 94. Asia Medical Radioisotopes Revenue by Application (2019-2024) & (US$ Million)
Table 95. Asia Medical Radioisotopes Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 96. Asia Medical Radioisotopes Revenue by Country (2019-2024) & (US$ Million)
Table 97. Asia Medical Radioisotopes Revenue by Country (2025-2030) & (US$ Million)
Table 98. MEALA Medical Radioisotopes Revenue by Type (2019-2024) & (US$ Million)
Table 99. MEALA Medical Radioisotopes Revenue by Application (2019-2024) & (US$ Million)
Table 100. MEALA Medical Radioisotopes Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 101. MEALA Medical Radioisotopes Revenue by Country (2019-2024) & (US$ Million)
Table 102. MEALA Medical Radioisotopes Revenue by Country (2025-2030) & (US$ Million)
Table 103. Research Programs/Design for This Report
Table 104. Authors List of This Report
Table 105. Secondary Sources
Table 106. Primary Sources
List of Figures
Figure 1. Medical Radioisotopes Product Picture
Figure 2. Global Medical Radioisotopes Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Medical Radioisotopes Market Size Share 2019 VS 2023 VS 2030
Figure 4. Tc-99m Picture
Figure 5. Cobalt-60 Picture
Figure 6. Iodine Radioisotopes Picture
Figure 7. Global Medical Radioisotopes Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Medical Radioisotopes Market Size Share 2019 VS 2023 VS 2030
Figure 9. Nuclear Therapy Picture
Figure 10. Equipment Radioactive Source Picture
Figure 11. Diagnosis Picture
Figure 12. Others Picture
Figure 13. Global Medical Radioisotopes Market Size (US$ Million) & (2019-2030)
Figure 14. Global Medical Radioisotopes Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Medical Radioisotopes Market Share by Region: 2019 VS 2023 VS 2030
Figure 16. Global Medical Radioisotopes Players Revenue Share Top 10 and Top 5 in 2023
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global Medical Radioisotopes Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Medical Radioisotopes Revenue Market Share 2019 VS 2023 VS 2030
Figure 20. Global Medical Radioisotopes Revenue Market Share by Type (2019-2030)
Figure 21. Global Medical Radioisotopes Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Medical Radioisotopes Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 23. Global Medical Radioisotopes Revenue Market Share by Application (2019-2030)
Figure 24. North America Medical Radioisotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Medical Radioisotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 26. North America Medical Radioisotopes Revenue Share by Type (2019-2030)
Figure 27. North America Medical Radioisotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 28. North America Medical Radioisotopes Revenue Share by Application (2019-2030)
Figure 29. North America Medical Radioisotopes Revenue Share by Country (2019-2030)
Figure 30. United States Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Canada Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Europe Medical Radioisotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Medical Radioisotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 34. Europe Medical Radioisotopes Revenue Share by Type (2019-2030)
Figure 35. Europe Medical Radioisotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 36. Europe Medical Radioisotopes Revenue Share by Application (2019-2030)
Figure 37. Europe Medical Radioisotopes Revenue Share by Country (2019-2030)
Figure 38. Germany Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. France Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. U.K. Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Italy Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Russia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Nordic Countries Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. China Medical Radioisotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Medical Radioisotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 46. China Medical Radioisotopes Revenue Share by Type (2019-2030)
Figure 47. China Medical Radioisotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 48. China Medical Radioisotopes Revenue Share by Application (2019-2030)
Figure 49. Asia Medical Radioisotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 50. Asia Medical Radioisotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 51. Asia Medical Radioisotopes Revenue Share by Type (2019-2030)
Figure 52. Asia Medical Radioisotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 53. Asia Medical Radioisotopes Revenue Share by Application (2019-2030)
Figure 54. Asia Medical Radioisotopes Revenue Share by Country (2019-2030)
Figure 55. Japan Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. South Korea Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. India Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Australia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. China Taiwan Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Southeast Asia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. MEALA Medical Radioisotopes Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 62. MEALA Medical Radioisotopes Revenue by Type (2025-2030) & (US$ Million)
Figure 63. MEALA Medical Radioisotopes Revenue Share by Type (2019-2030)
Figure 64. MEALA Medical Radioisotopes Revenue by Application (2025-2030) & (US$ Million)
Figure 65. MEALA Medical Radioisotopes Revenue Share by Application (2019-2030)
Figure 66. MEALA Medical Radioisotopes Revenue Share by Country (2019-2030)
Figure 67. Mexico Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. South Korea Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Brazil Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Israel Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Argentina Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Colombia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Turkey Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Saudi Arabia Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. UAE Medical Radioisotopes Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
